Improved Adenoviral Vectors for Hepatic Gene Therapy
用于肝脏基因治疗的改良腺病毒载体
基本信息
- 批准号:6873620
- 负责人:
- 金额:$ 32.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-09-30 至 2007-03-31
- 项目状态:已结题
- 来源:
- 关键词:biotechnologycomputer assisted sequence analysisdisease /disorder modeldogsgel electrophoresisgene deletion mutationgene expressiongene therapygenomehemophilia Bhost organism interactionintegraselaboratory mouseliverliver cellsnucleic acid sequenceplasmidsprotein protein interactionprotein structure functiontissue /cell culturetransfection /expression vectortransposon /insertion elementvirus proteinyeast two hybrid system
项目摘要
DESCRIPTION (provided by applicant):
Recombinant adenoviral vectors have had a stormy history. Nevertheless, there is promise in the development of gene-deleted adenoviruses because of reduced toxicity, efficient gene transfer, and large DNA carrying capacity. The goal of this project is to develop scientific principles required for production and evaluation of gene-deleted adenoviral vectors that remain episomal and/or integrate into host chromosomal DNA. The new vectors will be assessed in animals for efficacy as well as safety with the primary focus being on liver gene transfer. Using DNA transposons and site-specific phage integrases, we plan to develop gone-deleted vectors that can integrate an expression cassette into the host chromosome. Both episomal and integrating gene deleted vectors will be compared for longevity of therapeutic gene expression in a dog model of hemophilia. This will allow us to establish the utility of use of the vector for treating genetic diseases where life-long gene expression is required in most situations. We will begin to attempt to unravel the molecular state of the vector DNA and identify cellular proteins that may be involved in stabilizing episomal adenoviral vector DNAs in vivo. Taken together, these studies will advance our basic understanding of vector-host interactions related to persistence of vector in rive, as well as advancing therapeutic applications in preclinical development.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark A Kay其他文献
AAV vectors and tumorigenicity
腺相关病毒载体与致瘤性
- DOI:
10.1038/nbt1007-1111 - 发表时间:
2007-10-01 - 期刊:
- 影响因子:41.700
- 作者:
Mark A Kay - 通讯作者:
Mark A Kay
RNA interference gene therapy: RNA interference gets infectious
RNA干扰基因疗法:RNA干扰具有传染性
- DOI:
10.1038/sj.gt.3302035 - 发表时间:
2003 - 期刊:
- 影响因子:5.1
- 作者:
Ap Mccaffrey;Mark A Kay;Anton P. McCaffrey;Mark A Kay - 通讯作者:
Mark A Kay
Mark A Kay的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark A Kay', 18)}}的其他基金
3' tsRNAs: biologic function and pre-clinical targeting for treating human disease
3 tsRNA:治疗人类疾病的生物学功能和临床前靶向
- 批准号:
10735190 - 财政年份:2023
- 资助金额:
$ 32.18万 - 项目类别:
The role of small RNA derived tRNAs in gene regulation: Mechanism and Therapeutic Applications
小RNA衍生的tRNA在基因调控中的作用:机制和治疗应用
- 批准号:
9763548 - 财政年份:2017
- 资助金额:
$ 32.18万 - 项目类别:
The role of small RNA derived tRNAs in gene regulation: Mechanism and Therapeutic Applications
小RNA衍生的tRNA在基因调控中的作用:机制和治疗应用
- 批准号:
9365781 - 财政年份:2017
- 资助金额:
$ 32.18万 - 项目类别:
Selection of New rAAV Vectors Using Replicating Viral Capsids Libraries
使用复制病毒衣壳文库选择新的 rAAV 载体
- 批准号:
8861132 - 财政年份:2015
- 资助金额:
$ 32.18万 - 项目类别:
AAV capsid engineering for enhancing gene transfer
用于增强基因转移的 AAV 衣壳工程
- 批准号:
10574568 - 财政年份:2015
- 资助金额:
$ 32.18万 - 项目类别:
Selection of New rAAV Vectors Using Replicating Viral Capsids Libraries
使用复制病毒衣壳文库选择新的 rAAV 载体
- 批准号:
9022412 - 财政年份:2015
- 资助金额:
$ 32.18万 - 项目类别:
AAV capsid engineering for enhancing gene transfer
用于增强基因转移的 AAV 衣壳工程
- 批准号:
10352396 - 财政年份:2015
- 资助金额:
$ 32.18万 - 项目类别:
Molecular Evolution Strategies to Derive New Recombinant AAV Vectors
衍生新重组 AAV 载体的分子进化策略
- 批准号:
8230691 - 财政年份:2009
- 资助金额:
$ 32.18万 - 项目类别:
Molecular Evolution Strategies to Derive New Recombinant AAV Vectors
衍生新重组 AAV 载体的分子进化策略
- 批准号:
8044028 - 财政年份:2009
- 资助金额:
$ 32.18万 - 项目类别: